ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
University of Chicago
Bayer
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Terremoto Biosciences Inc.
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Tizona Therapeutics, Inc
Genentech, Inc.
Normunity AccelCo, Inc.
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
University of Colorado, Denver
MacroGenics
SystImmune Inc.
Daiichi Sankyo
Eli Lilly and Company
Adela, Inc
Orano Med LLC
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Medical College of Wisconsin
Innate Pharma
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Tanabe Pharma America, Inc.
University of Southern California
Radiopharm Theranostics, Ltd
DualityBio Inc.
Massachusetts General Hospital
Washington University School of Medicine
University of Pittsburgh
Rondo Therapeutics
LigaChem Biosciences, Inc.
Washington University School of Medicine
Institut Claudius Regaud
Travera Inc
Anhui Provincial Hospital
Nurix Therapeutics, Inc.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Yuhan Corporation
Marengo Therapeutics, Inc.